[1] |
Usman S, Anthony EL, Mario M. Neuroimaging advances in Parkinson's disease and atypical Parkinsonian syndromes[J]. Front Neurol, 2020, 15(11):572976.
|
[2] |
Rose BC, Liliana M, Bradford C, et al. Basal and evoked neurotransmitter levels in Parkin,DJ-1,PINK1 and LRRK2 knockout rat striatum[J]. Neuroscience, 2019, 15(409):169-179.
|
[3] |
Onur S, Nese O, Mehmet FO. Comparison of pramipexole versus ropinirole in the treatment of Parkinson's disease[J]. Ideggyogy Sz, 2022, 75(2):39-49.
doi: 10.18071/isz.75.0039
URL
|
[4] |
Huang ST, Dong YC, Zhao JY. The mean kurtosis (MK) is more sensitive diagnostic biomarker than fractional anisotropy (FA) for Parkinson's disease: A diagnostic performance study and meta-analysis[J]. Medicine (Baltimore), 2022, 101(45):e31312.
doi: 10.1097/MD.0000000000031312
URL
|
[5] |
Silvia LP. Diffusion tensor imaging (DTI)[J]. Methods Mol Biol, 2018, 1718:103-116.
|
[6] |
Zhang Y, Marc AB. Corrigendum: Diffusion tensor imaging in Parkinson's disease and Parkinsonian syndrome: A systematic review[J]. Front Neurol, 2020, 11:612069.
doi: 10.3389/fneur.2020.612069
URL
|
[7] |
Woo S, Byung J, Sung B, et al. Current clinical applications of diffusion-tensor imaging in neurological disorders[J]. J Clin Neurol, 2018, 14(2):129-140.
doi: 10.3988/jcn.2018.14.2.129
pmid: 29504292
|
[8] |
Hamed M, Saman S, Ebrahim K, et al. Probiotics and the treatment of Parkinson's disease: An update[J]. Cell Mol Neurobiol, 2022, 42(8):2449-2457.
doi: 10.1007/s10571-021-01128-w
|
[9] |
Tuva RH, Per S, Irena R, et al. Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease[J]. PLoS One, 2019, 14(5):0217922.
|
[10] |
Shang SA, Li DX, Tian YY, et al. Hybrid PET-MRI for early detection of dopaminergic dysfunction and microstructural degradation involved in Parkinson's disease[J]. Commun Biol, 2021, 4(1):1162.
doi: 10.1038/s42003-021-02705-x
pmid: 34621005
|
[11] |
Domínguez-Chávez CJ, Murrock CJ, Salazar-González BC. Mild cognitive impairment: A concept analysis[J]. Nurs Forum, 2019, 54(1):68-76.
doi: 10.1111/nuf.12299
pmid: 30261109
|
[12] |
Jennifer G, Erica S. Cognitive impairment and dementia in Parkinson disease[J]. Clin Geriatr Med, 2020, 36(2):365-377.
doi: S0749-0690(20)30001-X
pmid: 32222308
|
[13] |
高亚军, 刘峰, 高晓嵘. 脑白质微结构改变与帕金森病认知功能损害的相关性[J]. 陕西医学杂志, 2016, 45(4):448-449.
|
[14] |
Matsui H, Nishinaka K, Oda M, et al. Dementia in Parkinson's disease: Diffusion tensor imaging[J]. Acta Neurol Scand, 2007, 116(3):177-181.
doi: 10.1111/j.1600-0404.2007.00838.x
pmid: 17714331
|
[15] |
Wang WY, Mei MJ, Gao YY, et al. Changes of brain structural network connection in Parkinson's disease patients with mild cognitive dysfunction: A study based on diffusion tensor imaging[J]. J Neurol, 2020, 267(4):933-943.
doi: 10.1007/s00415-019-09645-x
pmid: 31792673
|
[16] |
Sebastiano G, Federica A, Elka S, et al. Structural brain connectome and cognitive impairment in Parkinson disease[J]. Radiology, 2017, 283(2):515-525.
doi: 10.1148/radiol.2016160274
pmid: 27924721
|
[17] |
Thais M, Li S, Elijah M, et al. Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study[J]. J Neurol, 2018, 265(7):1528-1539.
doi: 10.1007/s00415-018-8873-0
pmid: 29696499
|
[18] |
Naroa I, Carme J, Maria-Jose M, et al. Olfactory impairment in Parkinson's disease and white matter abnormalities in central olfactory areas: A voxel-based diffusion tensor imaging study[J]. Mov Disord, 2010, 25(12):1888-1894.
doi: 10.1002/mds.23208
URL
|
[19] |
梁红红. 帕金森病伴嗅觉障碍患者的弥散张量成像研究[D]. 郑州: 郑州大学, 2019.
|
[20] |
Nigro P, Chiappiniello A, Simoni S, et al. Changes of olfactory tract in Parkinson's disease: A DTI tractography study[J]. Neuroradiology, 2021, 63(2):235-242.
doi: 10.1007/s00234-020-02551-4
|
[21] |
Hossein S, Mahsa D, Elaheh S, et al. Association of olfaction dysfunction with brain microstructure in prodromal Parkinson disease[J]. Neurol Sci, 2019, 40(2):283-291.
doi: 10.1007/s10072-018-3629-2
pmid: 30386933
|
[22] |
Zhang KY, Yu CS, Zhang YJ, et al. Voxel-based analysis of diffusion tensor indices in the brain in patients with Parkinson's disease[J]. Eur J Radiol, 2011, 77(2):269-273.
doi: 10.1016/j.ejrad.2009.07.032
pmid: 19692193
|
[23] |
Charalampos G, Marcel W, Nil D, et al. Olfactory impairment in Parkinson's disease studied with diffusion tensor and magnetization transfer imaging[J]. J Parkinsons Dis, 2017, 7(2):301-311.
|
[24] |
Joshi N, Rolheiser TM, Fisk JD, et al. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures,but not in substantia nigra[J]. J Neurol, 2017, 264(7):1497-1505.
doi: 10.1007/s00415-017-8555-3
pmid: 28653210
|
[25] |
Li ZH, Liu WG, Xiao CY, et al. Abnormal white matter microstructures in Parkinson's disease and comorbid depression: A whole-brain diffusion tensor imaging study[J]. Neurosci Lett, 2020, 735(1):135238.
doi: 10.1016/j.neulet.2020.135238
URL
|
[26] |
Osamu A, Hidenori Y, Kiyoto K, et al. Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression[J]. Psychiatry Res, 2010, 181(1):64-70.
doi: 10.1016/j.pscychresns.2009.07.007
URL
|
[27] |
Ning HX, Zhou H, Ren JR, et al. Zishen pingchan granules combined with pramipexole in the improvement of depressive symptoms in Parkinson's disease: A prospective, multicenter, randomized, double-blind, controlled clinical study[J]. J Transl Med, 2022, 20(1):357.
doi: 10.1186/s12967-022-03551-z
pmid: 35962349
|
[28] |
Stéphanie M, Eric J, Isabelle Klein. Cognitive dysfunction and brain atrophy in Susac syndrome[J]. J Neurol, 2020, 267(4):994-1003.
doi: 10.1007/s00415-019-09664-8
pmid: 31828475
|
[29] |
Hu Xi, Qian L, Zhang Y, et al. Topological changes in white matter connectivity network in patients with Parkinson's disease and depression[J]. Brain Imaging Behav, 2020, 14(6):2559-2568.
doi: 10.1007/s11682-019-00208-2
|
[30] |
Ambra S, Birgit H. Sleep in Parkinson's disease[J]. Neuropsychopharmacology, 2020, 45(1):121-128.
doi: 10.1038/s41386-019-0448-y
pmid: 31234200
|
[31] |
Andrew HF, Gordon WD, Michael JF, et al. Rapid eye movement sleep behavior disorder in Parkinson's disease: Magnetic resonance imaging study[J]. Mov Disord, 2013, 28(6):832-836.
doi: 10.1002/mds.25367
URL
|
[32] |
Lim JS, Shin SA, Lee JY, et al. Neural substrates of rapid eye movement sleep behavior disorder in Parkinson's disease[J]. Parkinsonism Relat Disord, 2016, 23(2):31-36.
doi: 10.1016/j.parkreldis.2015.11.027
URL
|
[33] |
Lisa O, Colette MS, Jodie RG. Tract-based spatial statistics reveal lower white matter integrity specific to idiopathic rapid eye movement sleep behavior disorder as a proxy for prodromal Parkinson's disease[J]. J Parkinsons Dis, 2019, 9(4):723-731.
|
[34] |
Rafail M, Kuangyu S, Artemios A, et al. Brain neuroimaging of rapid eye movement sleep behavior disorder in Parkinson's disease: A systematic review[J]. J Parkinsons Dis, 2022, 12(1):69-83.
|
[35] |
Zhou LC, Li GL, Zhang YY, et al. Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder[J]. Brain, 2021, 144(5):1488-1497.
doi: 10.1093/brain/awab039
pmid: 33880500
|